GluCl.CreON enables selective inhibition of molecularly defined pain circuits

Middleton SJ., Hu H., Perez-Sanchez J., Zuberi S., McGrath Williams J., Weir GA., Bennett DL.

DOI

10.1097/j.pain.0000000000002976

Type

Journal article

Journal

Pain

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

27/06/2023

Volume

Publish Ahead of Print

Permalink Original publication